A. Martin Lerner

6.3k total citations · 1 hit paper
146 papers, 4.1k citations indexed

About

A. Martin Lerner is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Martin Lerner has authored 146 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 48 papers in Infectious Diseases and 39 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Martin Lerner's work include Viral Infections and Immunology Research (37 papers), Herpesvirus Infections and Treatments (24 papers) and Viral gastroenteritis research and epidemiology (20 papers). A. Martin Lerner is often cited by papers focused on Viral Infections and Immunology Research (37 papers), Herpesvirus Infections and Treatments (24 papers) and Viral gastroenteritis research and epidemiology (20 papers). A. Martin Lerner collaborates with scholars based in United States, Israel and Belgium. A. Martin Lerner's co-authors include Milagros P. Reyes, James R. Tillotson, Maxwell Finland, J. L. Chason, Francis M. Wilson, Anil Jain, Kenny L. De Meirleir, Alison C. Bested, Daniel L. Peterson and Pradip Joshi and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

A. Martin Lerner

145 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

2003 819 citations A. Martin Lerner et al. profile →

Peers

A. Martin Lerner

EPIDE

PMH

CCM

ID

PHARM

J M Galama Netherlands

Howard E. Gary United States

Ben Z. Katz United States

John B. Zabriskie United States

Shan‐Tair Wang Taiwan

Leonard H. Sigal United States

Paul B. Beeson United Kingdom

Warren M. Gold United States

Joseph A. Bellanti United States

J W van der Meer Netherlands

J M Galama Netherlands

A. Martin Lerner

627 ×0.5

EPIDE

876 ×0.9

PMH

632 ×0.7

CCM

529 ×0.7

ID

200 ×0.5

PHARM

Citations per year, relative to A. Martin Lerner A. Martin Lerner (= 1×) peers J M Galama

Countries citing papers authored by A. Martin Lerner

Since Specialization

Citations

This map shows the geographic impact of A. Martin Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Martin Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Martin Lerner more than expected).

Fields of papers citing papers by A. Martin Lerner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Martin Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Martin Lerner. The network helps show where A. Martin Lerner may publish in the future.

Co-authorship network of co-authors of A. Martin Lerner

This figure shows the co-authorship network connecting the top 25 collaborators of A. Martin Lerner. A scholar is included among the top collaborators of A. Martin Lerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Martin Lerner. A. Martin Lerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lerner, A. Martin. (2021). The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?. 9(1). 6–9. 5 indexed citations

2.

Lerner, A. Martin, Maria E. Ariza, Marshall V. Williams, et al.. (2012). Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset. PLoS ONE. 7(11). e47891–e47891. 44 indexed citations

3.

Beqaj, Safedin, A. Martin Lerner, & James T. Fitzgerald. (2007). Immunoassay with cytomegalovirus early antigens from gene products p52 and CM₂ (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. Journal of Clinical Pathology. 61(5). 623–626. 28 indexed citations

4.

Somech, Raz, et al.. (2001). Focal Nodular Hyperplasia in Children. Journal of Pediatric Gastroenterology and Nutrition. 32(4). 480–483. 10 indexed citations

5.

Lerner, A. Martin, et al.. (1998). Adhesion-related abdominal wall varices: demonstration by color Doppler sonography.. American Journal of Roentgenology. 170(6). 1670–1670. 1 indexed citations

6.

Gilroy, John, et al.. (1995). ROLE OF BACTERIAL INFECTION IN EXACERBATION OF MULTIPLE SCLEROSIS. American Journal of Physical Medicine & Rehabilitation. 74(6). 415–418. 54 indexed citations

7.

Dworkin, Howard J., et al.. (1994). Abnormal Left Ventricular Myocardial Dynamics in Eleven Patients With Chronic Fatigue Syndrome. Clinical Nuclear Medicine. 19(8). 675–677. 21 indexed citations

8.

Lerner, A. Martin. (1990). Viral Myocarditis as an Incidental Discovery. Hospital Practice. 25(10). 81–90. 1 indexed citations

9.

Iancu, Theodore C., A. Martin Lerner, & Hanna Shiloh. (1987). Intestinal Mucosa in Nephropathic Cystinosis. Journal of Pediatric Gastroenterology and Nutrition. 6(3). 359–364. 9 indexed citations

10.

Corey, Lawrence, et al.. (1982). Historical Findings in Subjects from a High Socioeconomic Group Who Have Genital Infections with Herpes Simplex Virus. Sexually Transmitted Diseases. 9(1). 15–20. 22 indexed citations

11.

Lerner, A. Martin, et al.. (1982). Pharmacokinetics of Interferon in Blood, Cerebrospinal Fluid, and Brain after Administration of Modified Polyriboinosinic-Polyribocytidylic Acid and Amphotericin B. The Journal of Infectious Diseases. 146(6). 819–825. 4 indexed citations

12.

Reyes, Milagros P., et al.. (1981). A Mouse Model of Dilated-Type Cardiomyopathy Due to Coxsackievirus B3. The Journal of Infectious Diseases. 144(3). 232–236. 51 indexed citations

13.

Levy, H. B., et al.. (1980). Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components. Antimicrobial Agents and Chemotherapy. 18(3). 409–415. 6 indexed citations

14.

Wilson, Francis M. & A. Martin Lerner. (1978). A Cardiomyopathy of BALB/c Mice (Superimposed Infection by Coxsackievirus B-3). Experimental Biology and Medicine. 157(3). 442–448. 3 indexed citations

15.

Chason, J. L., et al.. (1970). AUGMENTATION OF THE VIRULENCE OF MURINE COXSACKIE-VIRUS B-3 MYOCARDIOPATHY BY EXERCISE. The Journal of Experimental Medicine. 131(6). 1121–1136. 112 indexed citations

16.

Carruthers, Mary M., et al.. (1970). Herpesvirus hominisEncephalitis in Michigan. New England Journal of Medicine. 282(1). 10–13. 72 indexed citations

17.

Lerner, A. Martin. (1968). Virus Myopericarditis. Annals of Internal Medicine. 69(5). 1068–1070. 7 indexed citations

18.

Carruthers, Mary M., et al.. (1966). CONGENITAL INFECTIONS WITH REOVIRUS. The Journal of Experimental Medicine. 124(1). 33–46. 17 indexed citations

19.

Lerner, A. Martin, et al.. (1966). Preparations of Saliva Inhibiting Reovirus Hemagglutination. The Journal of Immunology. 96(1). 59–63. 9 indexed citations

20.

Lerner, A. Martin, Howard S. Levin, & Maxwell Finland. (1962). AGE AND SUSCEPTIBILITY OF MICE TO COXSACKIE A VIRUSES. The Journal of Experimental Medicine. 115(4). 745–762. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact